| Description |
- Angiotensin Receptor-Neprilysin Inhibitor (ARNI): A new class of drug made from the combination of
two anti-hypertensive drugs (sacubitril and valsartan).
- Sacubitril blocks the breakdown of natriuretic peptides produced in the body. Natriuretic peptides
cause sodium and water to pass into the urine. This effect reduces the work on the heart and reduces
blood pressure.
- @Valsartan blocks the action of angiotensin II, which can be harmful in patients with heart failure.
This effect stops the hormone's harmful effects on the heart, and it allows blood. vessels to dilate
or widen.
- Sacubitril/Valsartan, proved superiority over other conventional heart failure management treatments.
|